Fexlamose is being developed as a chronic treatment for COPD and asthma in conjunction with standard therapies, to improve ...
Physicians recommend that patients with chronic obstructive pulmonary disease (COPD) quit smoking and use steroids, ...
For patients with COPD, budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol.
News Medical on MSN1d
Smoking before age 15 significantly increases risk of chronic lung diseaseA study reveals childhood smoking significantly increases COPD risk in adulthood, highlighting the need for targeted ...
News Medical on MSN4d
Study finds no clinical advantage of budesonide inhaler over fluticasone in COPDA study compares budesonide-glycopyrrolate-formoterol and fluticasone-umeclidinium-vilanterol, revealing insights on COPD ...
chronic obstructive pulmonary disease (COPD), and patients who have received a lung transplant. It ... How a New Gut Microbe Drives the Gut-Lung Axis Dec. 19, 2024 — A team has discovered a new ...
GlobalData on MSN1d
AerWave Medical concludes study of ultrasound therapy for COPDThe study, involving five patients, demonstrated the procedural efficiency and feasibility of AerWave's technology.
HealthDay News — There is a bidirectional association between rheumatoid arthritis (RA) and chronic obstructive pulmonary disease (COPD), according to a review published online Dec. 1 in Frontiers in ...
The Texas Tech University Health Sciences Center is offering a new treatment for patients suffering from severe chronic ...
Verona Pharma (VRNA) stock in focus as company reports early sales for Q4 and 2024 thanks to its lung disease therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback